Raymond James Financial’s Vaxart VXRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-236,166
Closed -$107K 6765
2025
Q2
$107K Buy
236,166
+34,075
+17% +$14.8K ﹤0.01% 4840
2025
Q1
$82.3K Buy
202,091
+6,643
+3% +$4.26K ﹤0.01% 4580
2024
Q4
$129K Buy
+195,448
New +$136K ﹤0.01% 4489

Other funds holding VXRT

Raymond James Financial's VXRT Position: Q3 2025 in Review

Raymond James Financial sold out of Vaxart (VXRT) in Q3 2025, closing a stake of 236,166 shares — an estimated $107K sold.

Raymond James Financial first reported a position in VXRT in Q4 2024 and held it in 3 quarters. The position peaked at $129K in Q4 2024. 17 funds tracked by Wall St. Rank hold VXRT as of Q3 2025.

  • Raymond James Financial reported no remaining Vaxart position as of Q3 2025 after selling out during the quarter.
  • Raymond James Financial sold 236,166 Vaxart shares in Q3 2025, an estimated $107K.
  • Raymond James Financial first reported a position in Vaxart in Q4 2024 and held it in 3 quarters.
  • Raymond James Financial's Vaxart position peaked at $129K in Q4 2024.
  • 17 funds tracked by Wall St. Rank held Vaxart as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.